Lymphocytic ascites with fever in Upper Egypt: tuberculosis or something else?
A 34-year-old woman, a farmer from a village near Sohag, presents with 8 weeks of progressive abdominal distension, evening fever of 37.8-38.4°C, night sweats and 6 kg weight loss. She has no jaundice, no alcohol use, no blood transfusion and no known liver disease. Examination shows shifting dullness, temperature 37.9°C, BMI 19, and no stigmata of chronic liver disease. Ascitic fluid is straw-coloured with 720 white cells/µL, 85% lymphocytes, SAAG 0.9 g/dL, total protein 4.4 g/dL, ADA 52 U/L and glucose 58 mg/dL. Serum albumin is 33 g/L, INR 1.1, platelets 240,000/µL, bilirubin normal and ALT 28 U/L. HIV serology, HBsAg and anti-HCV are negative. Chest radiograph shows a calcified focus in the right upper zone. Ultrasound shows ascites, a thickened peritoneum and no liver nodules; the portal vein is patent.
1. How do you interpret the ascitic fluid, and what is your differential diagnosis?
Read the worked answer
The serum-ascites albumin gradient is 0.9 g/dL, below the 1.1 g/dL threshold, so this is not ascites of portal hypertension. That single calculation rules out decompensated cirrhosis, cardiac ascites and portal vein thrombosis as the primary explanation, despite the low albumin and the setting. The fluid is a lymphocyte-predominant exudate with a protein of 4.4 g/dL, low glucose and a raised ADA, which points to peritoneal inflammation or malignancy.
The differential is led by peritoneal tuberculosis, which is common in Egypt and typically presents in young women with fever, night sweats, weight loss, and a subacute course. The calcified chest focus supports prior tuberculosis exposure. The main alternative is peritoneal carcinomatosis, particularly ovarian carcinoma, which can produce identical lymphocytic ascites with a raised CA-125; a raised CA-125 is not specific and occurs in tuberculous peritonitis too. Less likely possibilities are peritoneal mesothelioma, lymphomatous infiltration, chronic pancreatitis with pancreatic ascites, and, in the right epidemiological setting, brucellosis or other chronic infections.
What the fluid does not show is spontaneous bacterial peritonitis: the white cell count is below 500/µL and the patient has no cirrhosis. A diagnostic paracentesis with cell count, protein, albumin, ADA, glucose, LDH, cytology, mycobacterial culture and Xpert MTB/RIF should be sent before any empirical treatment; cytology is essential because ovarian cancer is the diagnosis that must not be missed.
2. Which confirmatory tests would you use, and is empirical anti-tuberculous therapy justified before they return?
Read the worked answer
Ascitic AFB smear is almost always negative and is not useful for exclusion. Mycobacterial culture of ascites has a sensitivity around 50%, takes weeks, and therefore cannot guide an urgent decision. Xpert MTB/RIF on ascitic fluid has modest sensitivity (roughly 30-50%) but is fast and gives rifampicin resistance information, so it should be sent. The highest-yield test is laparoscopic peritoneal biopsy with histology showing caseating granulomas and tissue culture, with a sensitivity above 85%; it also allows direct visualization of the characteristic miliary nodules and can exclude carcinomatosis. Where laparoscopy is unavailable, image-guided peritoneal biopsy is an alternative.
Cytology of a large-volume ascitic sample and gynaecological assessment, including pelvic ultrasound and CA-125 interpreted cautiously, are needed to exclude ovarian cancer before committing to a long course of tuberculosis treatment.
Empirical therapy is justified when the clinical picture is strongly supportive and malignancy has been reasonably excluded, particularly if biopsy is unavailable or delayed and the patient is symptomatic. The supportive features here are age, fever, night sweats, weight loss, a lymphocytic exudate with low glucose and ADA above 40 U/L, and a calcified chest focus. It is reasonable to start treatment while awaiting culture, with a documented plan to stop if an alternative diagnosis emerges. Empirical therapy without any attempt at tissue diagnosis is unacceptable.
3. Outline the treatment regimen and monitoring, and discuss the role of steroids, paradoxical reactions and contact tracing.
Read the worked answer
Standard treatment is a 6-month regimen: 2 months of isoniazid, rifampicin, pyrazinamide and ethambutol, followed by 4 months of isoniazid and rifampicin, all by directly observed or closely supported therapy. Doses should be weight-based, and baseline liver function, visual acuity and colour vision (ethambutol), plus renal function, should be documented. Pyridoxine is given to prevent isoniazid neuropathy, particularly in pregnancy, malnutrition or diabetes. If rifampicin resistance is detected, the regimen changes completely and specialist input is mandatory.
Steroids are established for tuberculous meningitis and pericarditis, but not for peritoneal tuberculosis; there is no good evidence that they prevent adhesions or improve cure, and they risk masking other diagnoses and worsening immunosuppression. A paradoxical reaction with fever, worsening ascites or new lymphadenopathy after starting therapy is common and is managed by excluding drug failure and resistance, then continuing treatment, adding supportive care, and only rarely using steroids.
Contact tracing of household members, screening for HIV and diabetes, and assessment of the patient's nutrition are part of the public health response. In Egypt, notification of tuberculosis is mandatory. Monitoring should include adherence and repeat liver enzymes if symptoms suggest hepatotoxicity, with discontinuation of the likely culprit drug if transaminases exceed three times normal with symptoms.